KEGG   DRUG: Inotersen sodiumHelp
Entry
D10941                      Drug                                   

Name
Inotersen sodium (USAN);
Tegsedi (TN)
Product
Formula
C230H299N69O121P19S19. 19Na
Exact mass
7595.7129
Mol weight
7600.7669
Remark
Chemical structure group: DG02693
Product (DG02693): D10941<US>
Efficacy
Neuroprotectant, Prealbumin expression inhibitor
  Disease
Hereditary transthyretin-mediated amyloidosis [DS:H00845]
Comment
Antisense oligonucleotide
Hereditary ATTR amyloidosis treatment
Target
TTR [HSA:7276] [KO:K20731] (mRNA)
Brite
Target-based classification of drugs [BR:br08310]
 Transporters
  Other transporters
   Others
    TTR
     D10941  Inotersen sodium (USAN) <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D10941
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10941
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10941
BRITE hierarchy
Other DBs
CAS: 1432726-13-0
PubChem: 342581795
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system